Trace Amine-Associated Receptor 1 Trafficking to Cilia of Thyroid Epithelial Cells.
G protein-coupled receptors
cilia
green fluorescent protein
thyroid auto-regulation
thyroid epithelial cells
trace amine-associated receptor 1
trafficking
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
16 06 2021
16 06 2021
Historique:
received:
14
05
2021
revised:
11
06
2021
accepted:
12
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Trace amine-associated receptor 1 (rodent Taar1/human TAAR1) is a G protein-coupled receptor that is mainly recognized for its functions in neuromodulation. Previous in vitro studies suggested that Taar1 may signal from intracellular compartments. However, we have shown Taar1 to localize apically and on ciliary extensions in rodent thyrocytes, suggesting that at least in the thyroid, Taar1 may signal from the cilia at the apical plasma membrane domain of thyrocytes in situ, where it is exposed to the content of the follicle lumen containing putative Taar1 ligands. This study was designed to explore mouse Taar1 (mTaar1) trafficking, heterologously expressed in human and rat thyroid cell lines in order to establish an in vitro system in which Taar1 signaling from the cell surface can be studied in future. The results showed that chimeric mTaar1-EGFP traffics to the apical cell surface and localizes particularly to spherical structures of polarized thyroid cells, procilia, and primary cilia upon serum-starvation. Moreover, mTaar1-EGFP appears to form high molecular mass forms, possibly homodimers and tetramers, in stably expressing human thyroid cell lines. However, only monomeric mTaar1-EGFP was cell surface biotinylated in polarized human thyrocytes. In polarized rat thyrocytes, mTaar1-EGFP is retained in the endoplasmic reticulum, while cilia were reached by mTaar1-EGFP transiently co-expressed in combination with an HA-tagged construct of the related mTaar5. We conclude that Taar1 trafficking to cilia depends on their integrity. The results further suggest that an in vitro cell model was established that recapitulates Taar1 trafficking in thyrocytes in situ, in principle, and will enable studying Taar1 signaling in future, thus extending our general understanding of its potential significance for thyroid autoregulation.
Identifiants
pubmed: 34208608
pii: cells10061518
doi: 10.3390/cells10061518
pmc: PMC8234161
pii:
doi:
Substances chimiques
Receptors, G-Protein-Coupled
0
Trace amine-associated receptor 1
XMC8VP6RI2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : BR 1308/11-1 and 11-2 to KBr
Organisme : Deutsche Forschungsgemeinschaft
ID : SP 583/7-1 to SSp
Références
Genes Brain Behav. 2007 Oct;6(7):628-39
pubmed: 17212650
J Pharmacol Exp Ther. 2008 Mar;324(3):948-56
pubmed: 18083911
Drug Discov Today. 2008 Dec;13(23-24):1059-66
pubmed: 18824244
Eur J Pharmacol. 2015 Aug 15;761:345-52
pubmed: 26092759
Mol Pharmacol. 2008 Sep;74(3):585-594
pubmed: 18524885
Eur Thyroid J. 2015 Sep;4(Suppl 1):30-41
pubmed: 26601071
Biochem Pharmacol. 2009 Nov 1;78(9):1095-104
pubmed: 19482011
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Mol Pharmacol. 2001 Dec;60(6):1181-8
pubmed: 11723224
Biochim Biophys Acta Mol Cell Res. 2020 Dec;1867(12):118846
pubmed: 32910988
Genomics. 2005 Mar;85(3):372-85
pubmed: 15718104
Mol Cells. 2019 Feb 28;42(2):113-122
pubmed: 30622229
J Biochem Biophys Methods. 1984 Dec;10(3-4):203-9
pubmed: 6530509
Hoppe Seylers Z Physiol Chem. 1979 Nov;360(11):1657-70
pubmed: 92445
J Cell Sci. 2014 Jul 1;127(Pt 13):2885-97
pubmed: 24806963
PLoS One. 2011 Apr 27;6(4):e19354
pubmed: 21556376
J Neurochem. 2011 Jan;116(2):164-76
pubmed: 21073468
Cell Death Dis. 2020 Jul 8;11(7):517
pubmed: 32641772
J Cell Biol. 1987 Feb;104(2):289-302
pubmed: 2879846
J Cell Sci. 2015 Apr 1;128(7):1294-307
pubmed: 25673876
Sci Rep. 2021 Feb 18;11(1):4181
pubmed: 33602982
Best Pract Res Clin Endocrinol Metab. 2018 Apr;32(2):83-91
pubmed: 29678288
Br J Cancer. 1989 Dec;60(6):897-903
pubmed: 2557880
J Clin Invest. 1998 Jul 15;102(2):283-93
pubmed: 9664069
Br J Pharmacol. 2009 Sep;158(1):5-14
pubmed: 19309353
Mol Pharmacol. 2009 Apr;75(4):751-61
pubmed: 19118123
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8485-90
pubmed: 21525407
J Clin Endocrinol Metab. 2008 Nov;93(11):4331-41
pubmed: 18713817
Front Pharmacol. 2018 Mar 20;9:221
pubmed: 29615904
Biochimie. 2019 Nov;166:270-285
pubmed: 31302164
Nucleic Acids Res. 1992 Jun 11;20(11):2902
pubmed: 1614888
Int J Mol Sci. 2014 Nov 10;15(11):20638-55
pubmed: 25391046
Methods Cell Biol. 2010;97:15-33
pubmed: 20719263
Nat Med. 1996 Aug;2(8):876-82
pubmed: 8705856
J Pharmacol Exp Ther. 2005 Jun;313(3):983-94
pubmed: 15764732
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):8966-71
pubmed: 11459929
Mol Pharmacol. 2011 Sep;80(3):416-25
pubmed: 21670104
PLoS One. 2015 Feb 23;10(2):e0117774
pubmed: 25706283
Exp Clin Endocrinol Diabetes. 2020 Jun;128(6-07):437-445
pubmed: 32074633
Pharmacol Ther. 2007 Dec;116(3):355-90
pubmed: 17888514
Thyroid Res. 2011 Aug 03;4 Suppl 1:S2
pubmed: 21835049
Endocr Rev. 2019 Apr 1;40(2):602-630
pubmed: 30649231
J Clin Endocrinol Metab. 2000 Aug;85(8):2889-96
pubmed: 10946899
Pharmacol Rev. 2010 Dec;62(4):701-25
pubmed: 21079041
J Virol. 2011 Apr;85(7):3473-85
pubmed: 21248040
Thyroid. 2019 Apr;29(4):595-606
pubmed: 30767621
Front Neurosci. 2016 Apr 05;10:148
pubmed: 27092049
Thyroid. 2017 Jan;27(1):11-22
pubmed: 27788620
J Leukoc Biol. 2013 Mar;93(3):387-94
pubmed: 23315425